GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Guardant Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$157.88−0.72 (-0.45%)
Close on Oct 19, 2026
- Market cap
- $20.98B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
99.8%
134M of 134M shares
Institutional holders
597
158 new, 41 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
1 buys · 142 sales
Net sold $173.82M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 6,895,256 | 5.20% | 13G (passive) amendment | Jun 30, 2026 |
| Vanguard Capital Management | 6,589,394 | 5.02% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,622,935 | 5.68% | $1.14B | −3,930,824 | 0.02% |
| Price T Rowe Associates Inc /Md/ | 6,514,952 | 4.85% | $977.44K | −508,737 | 0.10% |
| Vanguard Capital Management LLC | 5,755,857 | 4.29% | $863.55M | +131,677 | 0.02% |
| FMR LLC | 5,488,272 | 4.09% | $823.41M | +1,372,191 | 0.04% |
| Vanguard Portfolio Management LLC | 5,445,785 | 4.06% | $817.03M | −392,207 | 0.04% |
| Invesco Ltd. | 4,429,755 | 3.30% | $664.60M | −516,714 | 0.05% |
| Goldman Sachs Group Inc | 3,775,895 | 2.81% | $566.50M | −659,944 | 0.05% |
| Two Sigma Investments, LP | 3,719,301 | 2.77% | $558.01M | −510,230 | 0.40% |
| Capital International Investors | 3,399,604 | 2.53% | $510.04M | −81,714 | 0.11% |
| Deep Track Capital, LP | 3,393,312 | 2.53% | $509.10M | +55,071 | 7.41% |
| Franklin Resources Inc | 3,236,065 | 2.41% | $485.51M | −212,128 | 0.11% |
| Ameriprise Financial Inc | 3,150,897 | 2.35% | $472.78M | +1,736,011 | 0.10% |
| Fuller & Thaler Asset Management, Inc. | 2,629,007 | 1.96% | $394.43M | +78,693 | 1.07% |
| Geode Capital Management, LLC | 2,521,596 | 1.88% | $378.41M | −987,287 | 0.02% |
| Baillie Gifford & Co | 2,284,127 | 1.70% | $342.69M | −1,574,919 | 0.31% |
| State Street Corp | 2,263,504 | 1.69% | $339.62M | −621,116 | 0.01% |
| Federated Hermes, Inc. | 1,999,178 | 1.49% | $299.94M | +111,594 | 0.43% |
| Eventide Asset Management, LLC | 1,957,828 | 1.46% | $293.79M | −404,551 | 3.93% |
| Lord, Abbett & Co. LLC | 1,813,491 | 1.35% | $272.08K | −85,622 | 0.78% |
| Jane Street Group, LLC | 1,783,444 | 1.33% | $267.57M | +1,778,641 | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 597 | 134M | 99.8% | 158 / 199 | 179 / 41 | 21M | 22M |
| Q1 2026 | 486 | 135M | 100.0% | 73 / 193 | 159 / 78 | 32M | 19M |
| Q4 2025 | 498 | 134M | 99.7% | 141 / 156 | 149 / 32 | 27M | 16M |
| Q3 2025 | 395 | 123M | 91.7% | 71 / 134 | 132 / 39 | 19M | 21M |
| Q2 2025 | 365 | 125M | 93.3% | 69 / 127 | 116 / 44 | 18M | 13M |
| Q1 2025 | 342 | 120M | 89.6% | 91 / 91 | 110 / 45 | 18M | 17M |
| Q4 2024 | 298 | 120M | 89.1% | 63 / 95 | 90 / 32 | 13M | 21M |
| Q3 2024 | 271 | 128M | 95.1% | 44 / 95 | 76 / 53 | 38M | 18M |
| Q2 2024 | 282 | 118M | 88.0% | 69 / 83 | 92 / 42 | 19M | 16M |
| Q1 2024 | 258 | 117M | 86.9% | 44 / 87 | 85 / 79 | 22M | 21M |
| Q4 2023 | 295 | 116M | 86.5% | 51 / 80 | 117 / 47 | 20M | 15M |
| Q3 2023 | 296 | 111M | 82.8% | 50 / 101 | 88 / 51 | 14M | 14M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of GH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3,999,645 | 2.98% | $600.07M | 0.03% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,888,524 | 2.15% | $433.37M | 0.23% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1,778,489 | 1.33% | $266.83M | 1.81% | Jun 30, 2026 |
| Franklin Dynatech Fund | 1,750,000 | 1.30% | $262.55M | 0.87% | Jun 30, 2026 |
| Fullerthaler Behavioral Small-Cap Growth | 1,729,500 | 1.29% | $259.48M | 4.20% | Jun 30, 2026 |
| Vanguard U.S. Growth Fund | 1,716,540 | 1.28% | $222.62M | 0.47% | May 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 1,665,905 | 1.24% | $249.94M | 0.53% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,520,630 | 1.13% | $228.14M | 0.23% | Jun 30, 2026 |
| Eventide Gilead Fund | 1,265,290 | 0.94% | $189.83M | 5.52% | Jun 30, 2026 |
| Growth Fund of America | 1,263,832 | 0.94% | $163.91M | 0.05% | May 31, 2026 |
| Invesco Discovery Fund | 1,058,225 | 0.79% | $137.24M | 1.75% | May 31, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 975,588 | 0.73% | $146.37M | 1.23% | Jun 30, 2026 |
| Growth Fund | 968,653 | 0.72% | $145.33M | 0.25% | Jun 30, 2026 |
| Federated Hermes Kaufmann Fund | 916,481 | 0.68% | $148.46M | 3.01% | Jul 31, 2026 |
| Vanguard Explorer Fund | 827,179 | 0.62% | $133.99M | 0.61% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Helmy Eltoukhy | Co-Chief Executive Officer, Director | 2,030,934 | 1.51% | Aug 27, 2026 |
| AmirAli Talasaz | Co-Chief Executive Officer, Director | 37,500 | 0.03% | Aug 24, 2026 |
| Darya Chudova | Chief Technology Officer | 80,173 | 0.06% | Sep 17, 2026 |
| Kumud Kalia | Chief Information Officer | 39,794 | 0.03% | Sep 14, 2026 |
| Terilyn J. Monroe | Chief People Officer | 69,279 | 0.05% | Aug 13, 2026 |
| John G. Saia | Chief Legal Officer | 38,991 | 0.03% | Aug 12, 2026 |
| Chris Freeman | Chief Commercial Officer | 65,374 | 0.05% | Aug 11, 2026 |
| Michael Brian Bell | Chief Financial Officer | 51,816 | 0.04% | Jul 2, 2026 |
| Craig Eagle | Chief Medical Officer | 72,421 | 0.05% | Apr 2, 2026 |
| Roberto Mignone | Director | 10,274 | 0.01% | Sep 22, 2026 |
| Medina Manuel Hidalgo | Director | 5,020 | 0.00% | Sep 21, 2026 |
| Alex M. Azar II | Director | 825 | 0.00% | Sep 17, 2026 |
| Steve E. Krognes | Director | 10,177 | 0.01% | Sep 17, 2026 |
| Musa Tariq | Director | 11,449 | 0.01% | Sep 17, 2026 |
| Ian T. Clark | Director | 2,975 | 0.00% | Aug 5, 2026 |
| Myrtle S. Potter | Director | 20,971 | 0.02% | Jun 23, 2026 |
| Vijaya Gadde | Director | 28,517 | 0.02% | Jun 22, 2026 |
| Meghan V. Joyce | Director | 15,386 | 0.01% | Jun 22, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Roberto Mignone Director | Sep 21, 2026 | Option exercise | +264 | – | – | 10,274 |
| Medina Manuel Hidalgo Director | Sep 17, 2026 | Option exercise | +232 | – | – | 5,020 |
| Alex M. Azar II Director | Sep 16, 2026 | Sale(10b5-1 plan) | −826 | $175.00 | $144.55K | 825 |
| Steve E. Krognes Director | Sep 16, 2026 | Sale | −3,300 | $175.42 | $578.89K | 10,177 |
| Steve E. Krognes Director | Sep 16, 2026 | Sale | −1,300 | $176.34 | $229.24K | 8,877 |
| Steve E. Krognes Director | Sep 16, 2026 | Sale | −971 | $177.48 | $172.33K | 7,906 |
| Steve E. Krognes Director | Sep 16, 2026 | Sale | −1,103 | $174.46 | $192.43K | 13,477 |
| Musa Tariq Director | Sep 16, 2026 | Sale(10b5-1 plan) | −116 | $175.00 | $20.30K | 11,449 |
| Darya Chudova Chief Technology Officer | Sep 15, 2026 | Sale | −7,738 | $178.00 | $1.38M | 70,635 |
| Musa Tariq Director | Sep 15, 2026 | Option exercise | +249 | – | – | 11,565 |
| Alex M. Azar II Director | Sep 12, 2026 | Option exercise | +1,651 | – | – | 1,651 |
| Kumud Kalia Chief Information Officer | Sep 11, 2026 | Sale | −4,000 | $158.05 | $632.20K | 39,794 |
| Helmy Eltoukhy Co-Chief Executive Officer, Director | Aug 26, 2026 | Other | −25,000 | – | – | 1,970,934 |
| Helmy Eltoukhy Co-Chief Executive Officer, Director | Aug 26, 2026 | Gift | −30,000 | – | – | 1,940,934 |
| Helmy Eltoukhy Co-Chief Executive Officer, Director | Aug 26, 2026 | Other | +25,000 | – | – | 60,000 |
| Roberto Mignone Director | Aug 21, 2026 | Option exercise | +264 | – | – | 10,010 |
| AmirAli Talasaz Co-Chief Executive Officer, Director | Aug 21, 2026 | Sale | −7,589 | $170.29 | $1.29M | 37,500 |
| AmirAli Talasaz Co-Chief Executive Officer, Director | Aug 21, 2026 | Sale | −9,023 | $168.20 | $1.52M | 65,977 |
| AmirAli Talasaz Co-Chief Executive Officer, Director | Aug 21, 2026 | Sale | −20,888 | $169.16 | $3.53M | 45,089 |
| Musa Tariq Director | Aug 17, 2026 | Sale(10b5-1 plan) | −116 | $156.45 | $18.15K | 11,316 |
| Medina Manuel Hidalgo Director | Aug 17, 2026 | Option exercise | +232 | – | – | 4,788 |
| Musa Tariq Director | Aug 15, 2026 | Option exercise | +250 | – | – | 11,432 |
| Terilyn J. Monroe Chief People Officer | Aug 12, 2026 | Option exercise | +14,012 | $28.61 | $400.88K | 69,279 |
| Terilyn J. Monroe Chief People Officer | Aug 12, 2026 | Sale | −3,704 | $163.41 | $605.27K | 65,575 |
| Terilyn J. Monroe Chief People Officer | Aug 12, 2026 | Sale | −9,934 | $164.27 | $1.63M | 55,641 |
| Terilyn J. Monroe Chief People Officer | Aug 12, 2026 | Sale | −19,014 | $165.16 | $3.14M | 36,627 |
| Terilyn J. Monroe Chief People Officer | Aug 12, 2026 | Sale | −13,248 | $166.11 | $2.20M | 23,379 |
| Terilyn J. Monroe Chief People Officer | Aug 12, 2026 | Sale | −400 | $167.92 | $67.17K | 22,979 |
| Terilyn J. Monroe Chief People Officer | Aug 12, 2026 | Option exercise | +32,288 | $20.14 | $650.28K | 55,267 |
| Helmy Eltoukhy Co-Chief Executive Officer, Director | Aug 11, 2026 | Gift | −35,000 | – | – | 1,995,934 |
| Helmy Eltoukhy Co-Chief Executive Officer, Director | Aug 11, 2026 | Gift | +35,000 | – | – | 35,000 |
| John G. Saia Chief Legal Officer | Aug 10, 2026 | Gift | −800 | – | – | 38,991 |
| AmirAli Talasaz Co-Chief Executive Officer, Director | Aug 10, 2026 | Gift | −75,000 | – | – | 1,824,351 |
| AmirAli Talasaz Co-Chief Executive Officer, Director | Aug 10, 2026 | Gift | +75,000 | – | – | 75,000 |
| Chris Freeman Chief Commercial Officer | Aug 10, 2026 | Sale | −17,413 | $170.24 | $2.96M | 65,374 |
| Chris Freeman Chief Commercial Officer | Aug 10, 2026 | Option exercise | +35,412 | $110.49 | $3.91M | 100,786 |
| Chris Freeman Chief Commercial Officer | Aug 10, 2026 | Option exercise | +28,193 | $28.37 | $799.84K | 128,979 |
| Chris Freeman Chief Commercial Officer | Aug 10, 2026 | Sale | −3,463 | $167.38 | $579.64K | 125,516 |
| Chris Freeman Chief Commercial Officer | Aug 10, 2026 | Sale | −7,365 | $168.79 | $1.24M | 118,151 |
| Chris Freeman Chief Commercial Officer | Aug 10, 2026 | Sale | −35,364 | $169.63 | $6.00M | 82,787 |
| Medina Manuel Hidalgo Director | Aug 5, 2026 | Option exercise | +950 | $32.55 | $30.92K | 6,256 |
| Medina Manuel Hidalgo Director | Aug 5, 2026 | Sale | −750 | $164.61 | $123.46K | 4,556 |
| Medina Manuel Hidalgo Director | Aug 5, 2026 | Sale | −950 | $163.95 | $155.75K | 5,306 |
| Ian T. Clark Director | Aug 4, 2026 | Sale | −5,092 | $158.80 | $808.61K | 2,975 |
| Ian T. Clark Director | Aug 4, 2026 | Option exercise | +6,833 | $50.57 | $345.54K | 17,155 |
| Ian T. Clark Director | Aug 4, 2026 | Option exercise | +2,255 | $91.11 | $205.45K | 10,322 |
| Ian T. Clark Director | Aug 4, 2026 | Sale | −9,088 | $158.98 | $1.44M | 8,067 |
| Roberto Mignone Director | Jul 21, 2026 | Option exercise | +264 | – | – | 9,746 |
| Medina Manuel Hidalgo Director | Jul 17, 2026 | Option exercise | +232 | – | – | 5,306 |
| Musa Tariq Director | Jul 16, 2026 | Sale(10b5-1 plan) | −116 | $163.29 | $18.94K | 11,182 |
| Musa Tariq Director | Jul 15, 2026 | Option exercise | +250 | – | – | 11,298 |
| AmirAli Talasaz Co-Chief Executive Officer, Director | Jul 1, 2026 | Option exercise | +23,997 | – | – | 1,906,722 |
| AmirAli Talasaz Co-Chief Executive Officer, Director | Jul 1, 2026 | Option exercise | +9,715 | – | – | 1,916,437 |
| AmirAli Talasaz Co-Chief Executive Officer, Director | Jul 1, 2026 | Tax withholding | −17,086 | $170.77 | $2.92M | 1,899,351 |
| Helmy Eltoukhy Co-Chief Executive Officer, Director | Jul 1, 2026 | Option exercise | +23,997 | – | – | 2,038,305 |
| Helmy Eltoukhy Co-Chief Executive Officer, Director | Jul 1, 2026 | Option exercise | +9,715 | – | – | 2,048,020 |
| Helmy Eltoukhy Co-Chief Executive Officer, Director | Jul 1, 2026 | Tax withholding | −17,086 | $170.77 | $2.92M | 2,030,934 |
| Kumud Kalia Chief Information Officer | Jul 1, 2026 | Tax withholding | −3,066 | $170.77 | $523.58K | 43,794 |
| Kumud Kalia Chief Information Officer | Jul 1, 2026 | Option exercise | +1,607 | – | – | 42,421 |
| Kumud Kalia Chief Information Officer | Jul 1, 2026 | Option exercise | +1,084 | – | – | 43,505 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Musa Tariq Director | Oct 16, 2026 | 116 | $19.24K | Oct 16, 2026 | Restricted Stock Lapse |
| Alex M. Azar II Director | Oct 14, 2026 | 69 | $11.03K | Oct 14, 2026 | Restricted Stock Lapse |
| Steve E. Krognes Director | Sep 16, 2026 | 6,674 | $1.17M | Sep 16, 2026 | Restricted Stock Lapse |
| Alex M. Azar II Director | Sep 16, 2026 | 826 | $144.55K | Sep 16, 2026 | Restricted Stock Lapse |
| Musa Tariq Director | Sep 16, 2026 | 116 | $20.30K | Sep 16, 2026 | Restricted Stock Lapse |
| Darya Chudova Officer | Sep 15, 2026 | 7,738 | $1.38M | Sep 15, 2026 | Restricted Stock Lapse - See Remarks |
| Kumud Kalia Officer | Sep 11, 2026 | 4,000 | $632.19K | Sep 11, 2026 | Restricted Stock Lapse - See Remarks |
| AmirAli Talasaz Officer | Aug 21, 2026 | 37,500 | $6.34M | Aug 21, 2026 | Founder Shares |
| Musa Tariq Director | Aug 17, 2026 | 116 | $18.15K | Aug 17, 2026 | Restricted Stock Lapse |
| Terilyn J. Monroe Officer | Aug 12, 2026 | 46,300 | $7.65M | Aug 12, 2026 | Employee Stock Option Exercise |
| Chris Freeman Officer | Aug 10, 2026 | 63,605 | $10.79M | Aug 10, 2026 | Employee Stock Option Exercise |
| Medina Manuel Hidalgo Director | Aug 5, 2026 | 1,700 | $279.20K | Aug 5, 2026 | Restricted Stock Lapse |
| Meghan V. Joyce Former Affiliate | Aug 5, 2026 | 11,183 | $1.80M | Aug 5, 2026 | Restricted Stock Lapse - See Remarks |
| Ian T. Clark Director | Aug 4, 2026 | 14,180 | $2.25M | Aug 4, 2026 | Restricted Stock Lapse - See Remarks |
| Musa Tariq Director | Jul 16, 2026 | 116 | $18.94K | Jul 16, 2026 | Restricted Stock Lapse |